• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Yeast Infection Market

    ID: MRFR/Pharma/2884-HCR
    203 Pages
    Kinjoll Dey
    October 2025

    Yeast Infection Market Research Report Information By Pathogen (Candida Albicans, Candida Glabrata, Candida Rugosa, Others), By Types (Vaginal Yeast Infection, Skin Yeast Infection, Throat Yeast Infection, Others), By Treatment (Drug Treatments, Surgery), By End Users (Hospital, Clinics, Ambulatory Centers) - Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Yeast Infection Market Infographic
    Purchase Options

    Yeast Infection Market Summary

    As per Market Research Future Analysis, the yeast infection market is projected to grow to USD 7.3 billion by 2032, with a CAGR of 6.5% from 2023 to 2032. The market is driven by the prevalence of candidiasis, particularly among women, and the increasing demand for effective treatments. Factors such as low immunity, lifestyle diseases, and the rise of autoimmune disorders contribute to the growing incidence of yeast infections. The introduction of innovative treatments, such as VIVJOA® and Brexafemme, marks significant advancements in the market. However, challenges such as side effects of existing treatments and the rise of alternative therapies may impact growth.

    Key Market Trends & Highlights

    The yeast infection market is witnessing significant growth driven by various factors.

    • Market Size: USD 7.3 billion by 2032; CAGR: 6.5% (2023-2032)
    • 70-75% of women experience vaginal yeast infections at least once in their lifetime.
    • Emerging treatments like VIVJOA® and Brexafemme represent major advancements in the market.
    • North America holds the largest market share due to high prevalence and advanced healthcare infrastructure.

    Market Size & Forecast

    Market Size USD 7.3 Billion by 2032
    CAGR 6.5% (2023-2032)
    Largest Regional Market North America

    Major Players

    Mycovia Pharmaceuticals, Inc.; Concerto Biosciences; Scynexis; Sanofi; Astellas Pharma Inc.; AstraZeneca; Pfizer Inc.

    Yeast Infection Market Drivers

    Market Growth Projections

    The Global Yeast Infection Market Industry is projected to experience substantial growth over the coming years. With a market value of 5.14 USD Billion in 2024, it is anticipated to reach 8.82 USD Billion by 2035, reflecting a CAGR of 5.02% from 2025 to 2035. This growth trajectory indicates a robust demand for effective treatment options and highlights the importance of addressing yeast infections as a public health concern.

    Impact of Lifestyle Changes

    Lifestyle changes, including diet and hygiene practices, are impacting the Global Yeast Infection Market Industry. Increased consumption of processed foods and sugars can lead to an imbalance in the body's natural flora, making individuals more susceptible to yeast infections. Furthermore, changes in personal hygiene practices, such as the use of scented products, may exacerbate the issue. As awareness of these factors grows, there is a corresponding increase in demand for preventive measures and treatments, thereby driving market growth.

    Growing Awareness and Education

    There is a notable increase in awareness and education regarding yeast infections, which significantly impacts the Global Yeast Infection Market Industry. Campaigns aimed at educating the public about symptoms, causes, and treatment options are becoming more prevalent. This heightened awareness encourages individuals to seek medical advice and treatment, thereby driving market growth. As more people understand the importance of addressing yeast infections, the market is projected to grow at a CAGR of 5.02% from 2025 to 2035, reaching an estimated 8.82 USD Billion by 2035.

    Advancements in Treatment Options

    Innovations in treatment options for yeast infections are propelling the Global Yeast Infection Market Industry forward. The development of new antifungal medications, including topical and oral treatments, enhances patient outcomes and satisfaction. Additionally, the introduction of over-the-counter products allows for greater accessibility and convenience for consumers. These advancements not only improve treatment efficacy but also expand the market by attracting a broader consumer base. As a result, the market is experiencing robust growth, reflecting the ongoing demand for effective solutions.

    Increase in Self-Medication Trends

    The trend of self-medication is becoming increasingly prevalent, influencing the Global Yeast Infection Market Industry. Many individuals prefer to manage mild yeast infections with over-the-counter treatments rather than consulting healthcare professionals. This shift towards self-care is driven by the desire for convenience and immediate relief. Consequently, the market is witnessing a surge in the availability of antifungal products in pharmacies and online platforms. This trend is expected to contribute significantly to market growth, as more consumers opt for accessible treatment options.

    Rising Prevalence of Yeast Infections

    The increasing incidence of yeast infections globally is a primary driver of the Global Yeast Infection Market Industry. Factors such as antibiotic use, hormonal changes, and lifestyle choices contribute to this rise. For instance, it is estimated that approximately 75 percent of women will experience at least one yeast infection in their lifetime. This growing prevalence is expected to push the market value to 5.14 USD Billion in 2024, as healthcare providers and patients seek effective treatments and preventive measures.

    Key Companies in the Yeast Infection Market market include

    Industry Developments

    • The key players of the market are increasing the production of vaginal yeast infection drugs.  
    • The awareness about yeast infection treatment is rising in the middle and other emerging markets. 

    Future Outlook

    Yeast Infection Market Future Outlook

    The Global Yeast Infection Market is projected to grow at a 5.02% CAGR from 2024 to 2035, driven by increasing awareness and advancements in treatment options.

    New opportunities lie in:

    • Develop innovative antifungal therapies targeting resistant yeast strains.
    • Expand telehealth services for remote diagnosis and treatment.
    • Invest in educational campaigns to raise awareness about yeast infection prevention.

    By 2035, the market is expected to exhibit robust growth, reflecting evolving consumer needs and enhanced treatment modalities.

    Market Segmentation

    By types 

    • Throat yeast infection 
    • Vaginal yeast infection 
    • Skin yeast infection 

    By geography 

    • Asia pacific 
    • Europe 
    • North America 
    • The Middle East and Africa 

    By pathogens 

    • Candida drugs 
    • Candida alb cans 
    • Candida drugs 

    By treatment 

    • Surgery 
    • Drug treatment 
    • Suppository 
    • Cream 
    • Tablet 
    • Ointment 

    Report overview 

    • Market overview highlights 
    • Analysis based upon COVID 19
    • Explanation upon the Market Dynamics
    • Value chain analysis
    • Market segmentation overview
    • The regional analysis
    • Competitive landscape analysis
    • Recent Developments

    Recent developments 

    • The key players of the market are increasing the production of vaginal yeast infection drugs.  
    • The awareness about yeast infection treatment is rising in the middle and other emerging markets. 

    The key players of the yeast infection market 

    • Sanofi
    • Astellas Pharma Inc
    • Synmedic Laboratories
    • Astra Zeneca
    • Synmedic Laboratories
    • Allergan
    • Pfizer Inc
    • Brundavan Laboratories
    • Merck & Co., Inc
    • Corden Pharma

    Report Scope

    Attribute/Metric Details
      Market Size 2032   USD 7.3 Billion
      CAGR ( 2023-2032)   6.5%
      Base Year   2021
      Forecast Period   2023-2032
      Historical Data   2020
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Pathogen, Types, Treatment, and End users
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Scynexis (US), Synmedic Laboratories (India), Merck & Co., Inc. (US), Astellas (Japan), Bayer AG (Germany), Mentis Pharma Ltd. (India), Abbott (US), Novartis AG (Switzerland), Pfizer Inc. (US), Sanofi (France), ALLERGAN (Ireland), AstraZeneca (UK)
      Key Market Opportunities   New treatment methods
      Key Market Drivers ·  Increasing prevalence of autoimmune diseases·  Continuously increasing geriatric population·  Increasing number of patients suffering from HIV

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    What is the projected CAGR for the Yeast Infection Market for the forecast period (2022-2030)?

    The projected CAGR is 6.5% for the forecast period (2022-2032).

    Who are the key players in the Yeast Infection Market?

    The players are Synmedic Laboratories (India), Scynexis (US), Astellas (Japan), Bayer AG (Germany), Merck & Co., Inc. (US), Abbott (US), Mentis Pharma Ltd. (India), Sanofi (France), Novartis AG (Switzerland), Pfizer Inc. (US), AstraZeneca (UK), ALLERGAN (Ireland), and others.

    What are the end users in the Yeast Infection Market?

    Yeast Infection Market end users are Hospital, Clinics, Ambulatory Centers.

    What are the types discussed in the Yeast Infection Market?

    Yeast Infection Market has types like a skin yeast infection, throat yeast infection, vaginal yeast infection, and others.

    Which region would lead to the global Yeast Infection Market?

    Americas would lead the Yeast Infection Market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials